Premium
Proliferation and glycosaminoglycans secretion in fibroblasts from psoriatic skin: differential responses to retinoids
Author(s) -
PRIESTLEY G.C.
Publication year - 1987
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.1987.tb07489.x
Subject(s) - glycosaminoglycan , secretion , psoriasis , differential effects , medicine , differential (mechanical device) , microbiology and biotechnology , dermatology , biology , endocrinology , anatomy , aerospace engineering , engineering
SUMMARY The effects of four retinoids, all‐trans‐retinoic acid (tretinoin), 13‐cis‐retinoic acid (isotretinoin), Ro 10–1670 (etrctin) and the arotinoid, Ro 15–0778, on fibroblast proliferation and glycosaminoglycans (GAG) secretion in vitro were studied. Fibroblast lines cultured from normal skin (HSF) were compared with those from lesional (PSA) and non‐lesional (PSB) psoriatic skin. In general, the retinoids inhibited proliferation; the action was cytostatic, in rank order tretinoin > isotretinoin > etretin > arotinoid. The psoriatic cells tended to be more sensitive than the HSF lines, overall mean proliferation values (± SEM), as a percentage of untreated controls being: HSF 72 ± 3, PSA 61 ± 3 and PSB 54 ± 3. Stimulation of GAG secretion at low concentrations (IO ‐7 M) of all four retinoids, declined as concentrations increased, and secretion was inhibited at IO ‐7 M) in PSB fibroblasts. Calculation of effects on GAG secretion due to changes in cell density confirmed the rank order for direct stimulation of secretion as arotinoid > etretin > isotretinoin > tretinoin. Electrophoresis of [ 3 H]‐labelled glycosaminoglycans secreted in the presence of 10 ‐7 M arotinoid showed that it was predominantly hyaluronic acid, as in untreated cells. These data confirm that different retinoids have contrasting levels of effects on mesenchymal cells and suggest a greater sensitivity to drugs in fibroblasts from psoriatic skin.